Neoadjuvant chemoradiotherapy demonstrates a long-term survival benefit in pancreatic cancer patients when compared to upfront surgery
1. The use of a neoadjuvant gemcitabine-based chemoradiotherapy before surgery and adjuvant gemcitabine increased the overall survival rate when compared ...




![Nanoparticle delivery of aurora kinase inhibitor may improve tumor treatment [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2016/02/20541_lores-350x250.jpg)
![Nanoliposome allows for targeted drug delivery to treat pancreatic cancer [PreClinical]](https://www.2minutemedicine.com/wp-content/uploads/2016/02/SolidLipidNanoparticle-350x250.jpg)



